GAP is one of the major pharmaceutical CDMOs in Europe and a leader in the soft gelatin capsule industry in the region.
For more than 70 years
GAP develops only top quality products in its advanced production facilities based in Greece, by exploiting the scientific expertise it has acquired throughout a 70-year course. The company’s core lines of activity include the production of softgel capsules and the development of private label pharmaceutical and nutraceutical products for a wide portfolio of clients worldwide.
On a B2C level, GAP develops and successfully markets its own nutraceutical brand Eviol, which is currently the market leader in the Greek food supplements sector.
GAP’s contract manufacturing of soft capsules is one of its primary activities. Since the 1970s, the company has used soft gelatin capsule technology, and is the pioneer and sole manufacturer in Greece, providing flexible and cost-effective services in accordance with EUGMP and HACCP.
GAP serves as CDMO for a number of partners in Europe, the Middle East, and Asia.
It’s in our nature
*According to a research with 2,833 physicians, Sep. – Oct. 2020